Dr. Daniel K. Miles, M.D.
Neurology (Neurology Physician)
- Medicare participating
At a glance
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 38
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
NY license 218571
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Medicare patients and services
- Medicare patients, 2024
- 38
- Services billed
- 46
- Patients’ average age
- 70
| Service | Times | Patients |
|---|---|---|
| Measurement of brain wave activity (eeg), 41-60 minutes | 16 | 16 |
| Measurement of brain wave activity (eeg), awake and drowsy | 12 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Lacosamide Other prescribers in New York, NY | 18 |
| Levetiracetam Other prescribers in New York, NY | 15 |
| Xcopri (cenobamate) | 14 |
| Topamax (topiramate) Other prescribers in New York, NY | 13 |
| Depakote Er (divalproex sodium) Other prescribers in New York, NY | 12 |
| Oxcarbazepine Other prescribers in New York, NY | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.